(Q46564749)

English

CYP2D6 genetic variation in healthy adults and psychiatric African-American subjects: implications for clinical practice and genetic testing

scientific article published on 21 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

CYP2D6 genetic variation in healthy adults and psychiatric African-American subjects: implications for clinical practice and genetic testing (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

genetic variation

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

author name string

Cai WM

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

Nikoloff DM

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

Pan RM

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

Fanti P

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

Fairchild M

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

Koch WH

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

Wedlund PJ

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

publication date

21 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

343-350

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500378

0 references

Obesity, physical inactivity, and risk for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern California

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Dextromethorphan O-demethylation polymorphism in an African-American population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Limited association of the 2988g > a single nucleotide polymorphism with CYP2D641 in black subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

New allelic arrangement CYP2D6*36 x 2 found in a Japanese poor metabolizer of debrisoquine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Estimating European admixture in African Americans by using microsatellites and a microsatellite haplotype (CD4/Alu).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

CYP2D6.10 present in human liver microsomes shows low catalytic activity and thermal stability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

21 January 2018

CYP2D6 Genotyping in Patients on Psychoactive Drug Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500378

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.TPJ.6500378

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16550211

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46564749&oldid=2139076152"